Cargando…

Forfeited hepatogenesis program and increased embryonic stem cell traits in young hepatocellular carcinoma (HCC) comparing to elderly HCC

BACKGROUND: Hepatocellular carcinoma (HCC) in young subjects is rare but more devastating. We hypothesize that genes and etiological pathways are unique to young HCC (yHCC; ≤40 years old at diagnosis) patients. We therefore compared the gene expression profiles between yHCCs and HCCs from elderly pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hsei-Wei, Hsieh, Tsung-Han, Huang, SSu-Yi, Chau, Gar-Yang, Tung, Chien-Yi, Su, Chien-Wei, Wu, Jaw-Ching
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826595/ https://www.ncbi.nlm.nih.gov/pubmed/24160375 http://dx.doi.org/10.1186/1471-2164-14-736

Ejemplares similares

Correction to: The Knapsack Problem with Forfeits
por: Cerulli, Raffaele, et al.
Publicado: (2020)

dBMHCC: A comprehensive hepatocellular carcinoma (HCC) biomarker database provides a reliable prediction system for novel HCC phosphorylated biomarkers
por: Chu, Yen-Wei, et al.
Publicado: (2020)

Decision making in elderly HCC
por: Trovato, M A, et al.
Publicado: (2011)

HCC, diet and metabolic factors: Diet and HCC
por: Montella, Maurizio, et al.
Publicado: (2011)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
por: Kotsari, Maria, et al.
Publicado: (2023)

Evaluation of fibrosis in cirrhotic elderly patients with HCC
por: Pesce, A, et al.
Publicado: (2011)

Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC
por: Wei, Yulong, et al.
Publicado: (2021)

Tertiary Prevention of HCC in Chronic Hepatitis B or C Infected Patients
por: Teng, Wei, et al.
Publicado: (2021)

Human Hepatocellular Carcinoma (HCC)
por: Buonaguro, Luigi
Publicado: (2020)

Astrocytes Do Not Forfeit Their Neuroprotective Roles After Surviving Intense Oxidative Stress
por: Bhatia, Tarun N., et al.
Publicado: (2019)

HCC: RNA-Sequencing in Cirrhosis
por: Wang, Haoyu, et al.
Publicado: (2023)

Human Cytomegalovirus Is Associated with Lower HCC Recurrence in Liver Transplant Patients
por: Hsu, Po-Jung, et al.
Publicado: (2021)

RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo
por: Wang, Wei, et al.
Publicado: (2014)

Intratumor heterogeneity in HCC
por: Friemel, Juliane, et al.
Publicado: (2015)

Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring
por: Sun, Na, et al.
Publicado: (2020)

Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation
por: Lai, Hong-Yue, et al.
Publicado: (2021)

MRI in detection of hepatocellular carcinoma (HCC)
por: Digumarthy, Subba R, et al.
Publicado: (2005)

Emerging Therapies for Hepatocellular Carcinoma (HCC)
por: Chakraborty, Eesha, et al.
Publicado: (2022)

Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
por: Bicer, Fuat, et al.
Publicado: (2023)

HCC surveillance results in earlier HCC detection: results from an Indian cohort
por: Kohli, Anita, et al.
Publicado: (2014)

Preoperative ALBI grade predicts the outcomes in non-B non-C HCC patients undergoing primary curative resection
por: Tsai, Yu-Chieh, et al.
Publicado: (2021)

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
por: De Battista, Davide, et al.
Publicado: (2021)

Nuclear Organization during Hepatogenesis in Zebrafish Requires Uhrf1
por: Madakashira, Bhavani P., et al.
Publicado: (2021)

Comparison between using hepatocellular carcinoma (HCC) risk scores and the HCC national guideline to identify high‐risk chronic hepatitis B patients for HCC surveillance in Thailand
por: Rattananukrom, Chitchai, et al.
Publicado: (2022)

GATA3 is downregulated in HCC and accelerates HCC aggressiveness by transcriptionally inhibiting slug expression
por: Zhang, Zhuoliang, et al.
Publicado: (2021)

GATA3 is downregulated in HCC and accelerates HCC aggressiveness by transcriptionally inhibiting slug expression
por: Zhang, Zhuoliang, et al.
Publicado: (2021)

HO-1 is a favorable prognostic factor for HBV-HCC patients who underwent hepatectomy
por: Yeh, Chun-Nan, et al.
Publicado: (2018)

The Mechanism of Rac1 in Regulating HCC Cell Glycolysis Which Provides Underlying Therapeutic Target for HCC Therapy
por: Ren, Yin-Xiang, et al.
Publicado: (2022)

Integrative module analysis of HCC gene expression landscapes
por: Li, Hongshi, et al.
Publicado: (2020)

Molecular network of HCC aggressiveness
por: Kim, Sang Geon, et al.
Publicado: (2015)

The Epigenetic Regulation of HCC Metastasis
por: Han, Tae-Su, et al.
Publicado: (2018)

Strategies for HCC target discovery
por: Molina-Sánchez, Pedro, et al.
Publicado: (2017)

Inflammatory Mechanisms of HCC Development
por: Refolo, Maria Grazia, et al.
Publicado: (2020)

The paradox of immunotherapy in NASH-HCC
por: Peng, Yao, et al.
Publicado: (2021)

HCC diagnosis DFP report
Publicado: (2021)

Diabetes medications and risk of HCC
por: Plaz Torres, Maria Corina, et al.
Publicado: (2022)

Case Report: Solitary metastasis to the appendix after curative treatment of HCC
por: Zhang, Zun-Yi, et al.
Publicado: (2023)

Study on the changes of CT texture parameters before and after HCC treatment in the efficacy evaluation and survival predication of patients with HCC
por: Zhou, Wei, et al.
Publicado: (2022)

Splenic Volume, an Easy-To-Use Predictor of HCC Late Recurrence for HCC Patients After Hepatectomy
por: Fang, Tongdi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qapsbkfglno9vodj00ltu5al71